APA (7th ed.) Citation

ME, B., D, E., RA, B., MF, B., K, W., AA, S., . . . KN, M. (2021). Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC). Gynecologic oncology, 161(2), 382. https://doi.org/10.1016/j.ygyno.2021.02.032

Chicago Style (17th ed.) Citation

ME, Buechel, et al. "Correlation of Imaging and Plasma Based Biomarkers to Predict Response to Bevacizumab in Epithelial Ovarian Cancer (EOC)." Gynecologic Oncology 161, no. 2 (2021): 382. https://doi.org/10.1016/j.ygyno.2021.02.032.

MLA (9th ed.) Citation

ME, Buechel, et al. "Correlation of Imaging and Plasma Based Biomarkers to Predict Response to Bevacizumab in Epithelial Ovarian Cancer (EOC)." Gynecologic Oncology, vol. 161, no. 2, 2021, p. 382, https://doi.org/10.1016/j.ygyno.2021.02.032.